In the BioHarmony Drug Report Database

"Preview" Icon

Avibactam

Avycaz, Zavicefta (avibactam) is a small molecule pharmaceutical. Avibactam was first approved as Avycaz on 2015-02-25. It is used to treat escherichia coli infections, intraabdominal infections, klebsiella infections, proteus infections, and pseudomonas infections in the USA. It has been approved in Europe to treat bacterial pneumonia, gram-negative bacterial infections, pneumonia, soft tissue infections, and urinary tract infections. Avycaz’s patents are valid until 2032-06-15 (FDA).

 

Trade Name

 

Zavicefta
 

Common Name

 

avibactam
 

ChEMBL ID

 

CHEMBL1689063
 

Indication

 

bacterial pneumonia, escherichia coli infections, gram-negative bacterial infections, intraabdominal infections, klebsiella infections, pneumonia, proteus infections, pseudomonas infections, soft tissue infections, urinary tract infections
 

Drug Class

 

Beta-lactamase inhibitors

Image (chem structure or protein)

Avibactam structure rendering